Skip to main content
Log in

Examination of the bactericidal and opsonic activity of normal human serum for a mucoid and nonmucoid strain ofPseudomonas aeruginosa

  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

The bactericidal and opsonic activity of fresh human serum (FHS) for a mucoid strain ofPseudomonas aeruginosa, 144M, and its spontaneous nonmucoid revertant, 144NM, was examined. Strain 144M was sensitive to the bactericidal activity of FHS, but strain 144NM was not. This bactericidal activity was due to the combined interaction of IgG and IgM with complement, activated through both pathways. Neither 144M nor 144NM was ingested by human polymorphonuclear leukocytes (PMNL) without FHS. Whereas maximal phagocytosis of 144M required only 5% FHS, comparable ingestion of 144NM required 25% FHS. Maximal phagocytosis of either 144M or 144NM required IgG, IgM, and complement. However, 144M required a heat-sensitive opsonic IgG, whereas 144NM required a heat-resistant IgG. Using selective absorption techniques, the targets for bactericidal and opsonic immunoglobulins on 144M and 144NM appeared to be different, suggesting that the variant 144NM had one or more altered, absent, or inaccessible cell surface components that account for differences in response to FHS and PMNL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature cited

  1. Baltimore, R. S., Mitchell, M. 1980. Immunologic investigations of mucoid strains ofPseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains. Journal of Infectious Diseases141:238–247.

    PubMed  Google Scholar 

  2. Bjornson, A. B., Michael, J. G. 1974. Factors in human serum promoting phagocytosis ofPseudomonas aeruginosa. I. Interaction of opsonins with the bacterium. Journal of Infectious Diseases130:S53-S59.

    PubMed  Google Scholar 

  3. Diaz, F., Masovich, L. L., Neter, E. 1980. Serogroups ofPseudomonas aeruginosa and the immune response of patients with cystic fibrosis. Journal of Infectious Diseases121:269–274.

    Google Scholar 

  4. Doggett, R. G. 1969. Incidence of mucoidPseudomonas aeruginosa from clinical sources. Applied Microbiology18:936–937.

    PubMed  Google Scholar 

  5. Eidinger, D., Bello, E., Mates, A. 1977. The heterocytotoxicity of human serum. I. Activation of the alternative complement pathway by heterologous target cells. Cellular Immunology29:174–186.

    PubMed  Google Scholar 

  6. Fine, D. P. 1977. Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function. Infection and Immunity16:124–128.

    PubMed  Google Scholar 

  7. Gallin, J. I., Clark, R. A., Frank, M. M. 1975. Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternative complement pathways. Clinical Immunology and Immunopathology3:334–346.

    PubMed  Google Scholar 

  8. Gibbs, D. L., Roberts, R. B. 1975. The interaction in vitro between human polymorphonuclear leukocytes andNeisseria gonorrhoeae cultivated in the chick embryo. Journal of Experimental Medicine141:155–171.

    PubMed  Google Scholar 

  9. Griffin, Jr., F. M. 1977. Opsonization, pp. 85–113. In: Day, N. K., Good, R. A. (eds.), Biological amplification systems in immunology. New York: Plenum Medical Book Co.

    Google Scholar 

  10. Hoiby, N., Olling, S. 1977.Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis onP. aeruginosa strains from patients with cystic fibrosis or other diseases. Acta Pathologica et Microbiologica Scandinavica, Section C85:107–114.

    Google Scholar 

  11. Mayer, M. M. 1961. Complement and complement fixation. pp. 133–153. In: Kabat, E. A. Mayer, M. M. (eds.). Experimental immunochemistry, 2d ed. Springfield: Charles C. Thomas.

    Google Scholar 

  12. Ogle, C. K., Ogle, J. D., Stinnett, J. C., Stace, P., Alexander, J. W. 1980. Different serum requirements for opsonization of two serologically identical strains ofPseudomonas aeruginosa. Immunological Communications9:677–691.

    PubMed  Google Scholar 

  13. Roe, E. A., Jones, R. J. 1974. Intracellular killing of different strains ofPseudomonas aeruginosa by human leukocytes. British Journal of Experimental Pathology55:336–343.

    PubMed  Google Scholar 

  14. Schiller, N. L., Friedman, G. L., Roberts, R. B. 1978. Role of serum factors in the phagocytosis of type 4 gonococci by human polymorphonuclear leukocytes, pp. 207–212. In: Brooks, G. F., Gotschlich, E. C., Holmes, K. K., Sawyer, W. B., Young, F. E. (eds.), Immunobiology ofNeisseria gonorrhoeae. Washington: American Society for Microbiology.

    Google Scholar 

  15. Stossel, T. P. 1973. Quantitative studies of phagocytosis. Kinetic effects of cations and heat-labile opsonin. The Journal of Cell Biology58:346–356.

    PubMed  Google Scholar 

  16. Thomassen, M. J., Demko, C. A. 1981. Serum bactericidal effect onPseudomonas aeruginosa isolates from cystic fibrosis patients. Infection and Immunity33:512–518.

    PubMed  Google Scholar 

  17. Thomassen, M. J., Demko, C. A., Boxerbaum, B., Stern, R. C., Kuchenbrod, P. J. 1979. Multiple isolates ofPseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis. Journal of Infectious Diseases140:873–880.

    PubMed  Google Scholar 

  18. Young, L. S., Armstrong, D. 1972. Human immunity toPseudomonas aeruginosa. I. In vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. Journal of Infectious Diseases126:257–276.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borowski, R.S., Schiller, N.L. Examination of the bactericidal and opsonic activity of normal human serum for a mucoid and nonmucoid strain ofPseudomonas aeruginosa . Current Microbiology 9, 25–30 (1983). https://doi.org/10.1007/BF01567129

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01567129

Keywords

Navigation